Klempa I, Spatny M, Menzel J, Baca I, Nustede R, Stöckmann F, Arnold W
Klinik für Allgemein- und Gefässchirurgie, Zentralkrankenhaus St.-Jürgen-Strasse, Bremen.
Chirurg. 1995 Apr;66(4):350-9.
Given an indication for surgery in patients with chronic pancreatitis, such as distal common bile duct obstruction, duodenal stenosis, or dilated pancreatic duct with stones and congestion, the surgeon must decide the type of operation to perform. A duodenopancreatectomy, the Whipple procedure, is widely considered to be the gold standard. It is highly effective in relieving pain and eliminating the structural abnormalities noted above. Duodenum-preserving resection of the head of the pancreas (DPRHP) seems to be an attractive alternative to pancreaticoduodenectomy (PD) in the treatment of chronic pancreatitis. In a clinical prospective randomized trial the efficiency of both operative methods was investigated. Between 7/1987 and 12/1993 43 patients were randomly assigned to undergo either a Whipple procedure (n = 21) or DPRHP (n = 22). Data on postoperative course, mortality, and postoperative morbidity were compiled. As concerns long-term results, postoperative hormonal status (insulin, neurotensin, cholecystokinin, gastrin) was checked, basal and stimulated with a standardized meal, using standard hormonal assay kits. All patients with PD survived, whereas one with DPRHP died from peritonitis. Patients with DPRHP had a significant more rapid convalescence (16.5 vs. 21.7 days). The range for postoperative follow-up is from 36 months to 5.5 years. In the DPRHP group 18 patients are in good condition. Two had diabetes and one developed carcinoma. In the PD group one died from hepatic coma, 14 are in good condition and 6 developed diabetes. All gained body weight with an average of 6.4 vs. 4.9 kg, DPRHP vs. PD. A difference between DPRHP and PD was obvious for the postoperative hormonal status. Results are satisfactory in both groups. For patients with DPRHP however, we see a quicker convalescence and a significant benefit as concerns postoperative hormonal status.
对于慢性胰腺炎患者,若有手术指征,如胆总管远端梗阻、十二指肠狭窄或胰管扩张伴结石及充血,外科医生必须决定实施何种手术。十二指肠胰切除术,即惠普尔手术,被广泛认为是金标准。它在缓解疼痛和消除上述结构异常方面非常有效。保留十二指肠的胰头切除术(DPRHP)似乎是治疗慢性胰腺炎时胰十二指肠切除术(PD)的一个有吸引力的替代方案。在一项临床前瞻性随机试验中,对这两种手术方法的疗效进行了研究。在1987年7月至1993年12月期间,43例患者被随机分配接受惠普尔手术(n = 21)或DPRHP(n = 22)。收集了术后病程、死亡率和术后发病率的数据。关于长期结果,使用标准激素检测试剂盒,在术后通过标准化餐食刺激后检查基础和刺激后的激素状态(胰岛素、神经降压素、胆囊收缩素、胃泌素)。所有接受PD的患者均存活,而1例接受DPRHP的患者死于腹膜炎。接受DPRHP的患者康复明显更快(16.5天对21.7天)。术后随访时间为36个月至5.5年。在DPRHP组中,18例患者状况良好。2例患有糖尿病,1例发生癌变。在PD组中,1例死于肝昏迷,14例状况良好,6例患糖尿病。两组患者体重均增加,DPRHP组平均增加6.4 kg,PD组平均增加4.9 kg。DPRHP和PD在术后激素状态方面存在明显差异。两组结果均令人满意。然而,对于接受DPRHP的患者,我们发现其康复更快,且在术后激素状态方面有显著益处。